The PAX7 target gene score, although not PAX7 itself, is significantly repressed in each of eight transcriptomic FSHD muscle biopsy studies, being unaffected by microarray/RNA‐seq technology or STIR positivity indicating inflammation (Banerji & Zammit, 2019) (Table 1). This evidence concerns the gene PAX7 and facioscapulohumeral muscular dystrophy.